Finnish pharmaceutical company Orion Pharma left Russia – Kommersant
[ad_1]
The Finnish pharmaceutical company Orion Pharma has stopped working in Russia, follows from its financial report for the first half of the year. Orion Pharma is the main manufacturer of Metipred (methylprednisolone, a hormonal anti-inflammatory drug), which is listed as an essential medicine.
According to document, published on its website, the company recorded a decrease in operating profit of € 25 million “due to the termination of business in Russia.” When exactly she left the Russian market is not specified.
How to draw attention “Pharmaceutical Bulletin”, the report does not say that Orion Pharma has stopped supplying drugs to Russia. However, data from Roszdravnadzor indicate a sharp reduction in the introduction of drugs from this company into circulation. In particular, since May 2022, it has not been supplying Divigel (estradiol) to Russia, which is used for hormone replacement therapy.
That Orion Pharma, which has been operating in Russia for 15 years, has begun to liquidate the Russian office, informed Vedomosti sources back in October 2022. The Russian division of the pharmaceutical company Orion Pharma in the same month assuredwhich continues to operate normally.
[ad_2]
Source link
